Amplifier Therapeutics
About:
Amplifier Therapeutics is a biopharmaceutical firm, developing AMP-activated protein kinase (AMPK) activator molecules.
Website: https://www.amplifier-tx.com
Top Investors: Cambrian Biopharma, RA Capital Management, Future Ventures
Description:
Amplifier Therapeutics is a biopharmaceutical firm, developing AMP-activated protein kinase (AMPK) activator molecules to treat aging-related disorders such as metabolic problems, cardiovascular diseases, kidney diseases, and cancer.
Total Funding Amount:
$33.3M
Headquarters Location:
New York, New York, United States
Founded Date:
2001-01-01
Founders:
Helena Edlund, Thomas Edlund
Number of Employees:
11-50
Last Funding Date:
2023-10-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai